These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

164 related articles for article (PubMed ID: 30971929)

  • 1. Transcriptome-Wide Effects of Sphingosine Kinases Knockdown in Metastatic Prostate and Breast Cancer Cells: Implications for Therapeutic Targeting.
    Alshaker H; Wang Q; Brewer D; Pchejetski D
    Front Pharmacol; 2019; 10():303. PubMed ID: 30971929
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Sphingosine Kinase 1 in Breast Cancer-A New Molecular Marker and a Therapy Target.
    Alshaker H; Thrower H; Pchejetski D
    Front Oncol; 2020; 10():289. PubMed ID: 32266132
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Characterization of isoenzyme-selective inhibitors of human sphingosine kinases.
    Gao P; Peterson YK; Smith RA; Smith CD
    PLoS One; 2012; 7(9):e44543. PubMed ID: 22970244
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Ablation of sphingosine kinase-2 inhibits tumor cell proliferation and migration.
    Gao P; Smith CD
    Mol Cancer Res; 2011 Nov; 9(11):1509-19. PubMed ID: 21896638
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Proteasomal degradation of sphingosine kinase 1 and inhibition of dihydroceramide desaturase by the sphingosine kinase inhibitors, SKi or ABC294640, induces growth arrest in androgen-independent LNCaP-AI prostate cancer cells.
    McNaughton M; Pitman M; Pitson SM; Pyne NJ; Pyne S
    Oncotarget; 2016 Mar; 7(13):16663-75. PubMed ID: 26934645
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Everolimus (RAD001) sensitizes prostate cancer cells to docetaxel by down-regulation of HIF-1α and sphingosine kinase 1.
    Alshaker H; Wang Q; Kawano Y; Arafat T; Böhler T; Winkler M; Cooper C; Pchejetski D
    Oncotarget; 2016 Dec; 7(49):80943-80956. PubMed ID: 27821815
    [TBL] [Abstract][Full Text] [Related]  

  • 7. The regulation of p53, p38 MAPK, JNK and XBP-1s by sphingosine kinases in human embryonic kidney cells.
    Alsanafi M; Kelly SL; McNaughton M; Merrill AH; Pyne NJ; Pyne S
    Biochim Biophys Acta Mol Cell Biol Lipids; 2020 Apr; 1865(4):158631. PubMed ID: 31954175
    [TBL] [Abstract][Full Text] [Related]  

  • 8. The cross roles of sphingosine kinase 1/2 and ceramide glucosyltransferase in cell growth and death.
    Qin J; Kilkus JP; Dawson G
    Biochem Biophys Res Commun; 2018 Jun; 500(3):597-602. PubMed ID: 29673590
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Role of sphingosine 1-phosphate receptors, sphingosine kinases and sphingosine in cancer and inflammation.
    Pyne NJ; McNaughton M; Boomkamp S; MacRitchie N; Evangelisti C; Martelli AM; Jiang HR; Ubhi S; Pyne S
    Adv Biol Regul; 2016 Jan; 60():151-159. PubMed ID: 26429117
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Downregulation of Critical Oncogenes by the Selective SK2 Inhibitor ABC294640 Hinders Prostate Cancer Progression.
    Schrecengost RS; Keller SN; Schiewer MJ; Knudsen KE; Smith CD
    Mol Cancer Res; 2015 Dec; 13(12):1591-601. PubMed ID: 26271487
    [TBL] [Abstract][Full Text] [Related]  

  • 11. De novo biosynthesis of dihydrosphingosine-1-phosphate by sphingosine kinase 1 in mammalian cells.
    Berdyshev EV; Gorshkova IA; Usatyuk P; Zhao Y; Saatian B; Hubbard W; Natarajan V
    Cell Signal; 2006 Oct; 18(10):1779-92. PubMed ID: 16529909
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Roles of the RAF/MEK/ERK and PI3K/PTEN/AKT pathways in malignant transformation and drug resistance.
    McCubrey JA; Steelman LS; Abrams SL; Lee JT; Chang F; Bertrand FE; Navolanic PM; Terrian DM; Franklin RA; D'Assoro AB; Salisbury JL; Mazzarino MC; Stivala F; Libra M
    Adv Enzyme Regul; 2006; 46():249-79. PubMed ID: 16854453
    [TBL] [Abstract][Full Text] [Related]  

  • 13. An oncogenic role for sphingosine kinase 2.
    Neubauer HA; Pham DH; Zebol JR; Moretti PA; Peterson AL; Leclercq TM; Chan H; Powell JA; Pitman MR; Samuel MS; Bonder CS; Creek DJ; Gliddon BL; Pitson SM
    Oncotarget; 2016 Oct; 7(40):64886-64899. PubMed ID: 27588496
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Roles, regulation and inhibitors of sphingosine kinase 2.
    Neubauer HA; Pitson SM
    FEBS J; 2013 Nov; 280(21):5317-36. PubMed ID: 23638983
    [TBL] [Abstract][Full Text] [Related]  

  • 15. The investigational Aurora kinase A inhibitor alisertib (MLN8237) induces cell cycle G2/M arrest, apoptosis, and autophagy via p38 MAPK and Akt/mTOR signaling pathways in human breast cancer cells.
    Li JP; Yang YX; Liu QL; Pan ST; He ZX; Zhang X; Yang T; Chen XW; Wang D; Qiu JX; Zhou SF
    Drug Des Devel Ther; 2015; 9():1627-52. PubMed ID: 25834401
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Therapeutic potential of targeting SK1 in human cancers.
    Alshaker H; Sauer L; Monteil D; Ottaviani S; Srivats S; Böhler T; Pchejetski D
    Adv Cancer Res; 2013; 117():143-200. PubMed ID: 23290780
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Targeting Sphingosine Kinases for the Treatment of Cancer.
    Lewis CS; Voelkel-Johnson C; Smith CD
    Adv Cancer Res; 2018; 140():295-325. PubMed ID: 30060814
    [TBL] [Abstract][Full Text] [Related]  

  • 18. CIB1 contributes to oncogenic signalling by Ras via modulating the subcellular localisation of sphingosine kinase 1.
    Zhu W; Gliddon BL; Jarman KE; Moretti PAB; Tin T; Parise LV; Woodcock JM; Powell JA; Ruszkiewicz A; Pitman MR; Pitson SM
    Oncogene; 2017 May; 36(18):2619-2627. PubMed ID: 27941888
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Inflammatory interferon activates HIF-1α-mediated epithelial-to-mesenchymal transition via PI3K/AKT/mTOR pathway.
    Yeh YH; Hsiao HF; Yeh YC; Chen TW; Li TK
    J Exp Clin Cancer Res; 2018 Mar; 37(1):70. PubMed ID: 29587825
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Amyloid-β precursor protein promotes cell proliferation and motility of advanced breast cancer.
    Lim S; Yoo BK; Kim HS; Gilmore HL; Lee Y; Lee HP; Kim SJ; Letterio J; Lee HG
    BMC Cancer; 2014 Dec; 14():928. PubMed ID: 25491510
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 9.